News
Tiger BioSciences Announces Acquisition of Advanced Wound Care Technology, Expanding Its Autologous Wound Dressing Therapy Capabilities
CONSHOHOCKEN, PA, Jan 06, 2026
Tiger BioSciences, a leader in regenerative medicine and tissue innovation, today announced the acquisition of Platelet-Rich Fibrin Matrix (PRFM) technology for advanced wound care, including its proprietary PRFM tubes and unique wound dressing platform from Bahia Medical Inc.
…
Tiger BioSciences Announces Launch of New Dermatology Division, Expanding Access to Advanced Wound Care and Aesthetic Solutions
CONSHOHOCKEN, PA, Jan 05, 2026
Tiger BioSciences today announced the official launch of its Dermatology Division, marking a significant expansion of the company’s wound care and aesthetic footprint. This new division will provide dermatologists nationwide with direct access to Tiger Wound Care’s advanced placental-derived wound care tissue products, HealPack™ surgical dressings, and Tiger Aesthetics’ cosmetic portfolio.
…
Tiger BioSciences Spotlights Major Clinical and Scientific Milestones Following Significant 2025 Research Investment
CONSHOHOCKEN, PA, December 30, 2025
Tiger BioSciences highlights a series of major clinical and scientific achievements resulting from the company’s expanded investment in evidence‑based research throughout 2025. This strategic focus has strengthened Tiger BioSciences’ position as a market leader heading into 2026, with a portfolio increasingly defined by data, clinical validation, and scientific evidence.
…
Tiger BioSciences Highlights Study on Advanced Placental CAMP Technologies
CONSHOHOCKEN, PA, December 08, 2025
Tiger BioSciences is spotlighting a pivotal study originally published in the International Journal of Molecular Sciences. The research evaluates placental-derived allograft technologies and their potential to transform wound care through improved biological preservation.
…
Tiger BioSciences Highlights Key Findings from Study on Multi-Layer Placental Allografts
CONSHOHOCKEN, PA, November 28, 2025
Tiger BioSciences is drawing attention to a foundational study that continues to shape the future of Cellular Acellular and Matrix like Products (CAMPs). Published in the International Journal of Molecular Sciences, the research compares 2-, 3-, and 4-layer placental-derived allografts, offering critical insights into how structural preservation influences biochemical composition.
…
Tiger BioSciences: Groundbreaking Study Demonstrates Significant Impact of Placental Allografts in Complex, Chronic Wound Care
CONSHOHOCKEN, PA, November 21, 2025
Complex, chronic wounds are increasingly recognized as life-altering conditions with mortality rates rivaling or surpassing certain cancers.
…
Tiger BioSciences Headlines IPAWS Conference, Showcases Extensive Clinical Data in Wound Care
CONSHOHOCKEN, PA, November 14, 2025
Tiger BioSciences proudly served as the headline sponsor of the International Post-Acute Wound Care Society Summit (IPAWS) Conference, held November 13–14. At the event, Tiger BioSciences reinforced its leadership in wound care innovation by presenting significant peer-reviewed clinical information and highlighting its data-driven approach to advancing patient outcomes.
…
Tiger BioSciences Showcases Robust Clinical Evidence for its Products in Support of CMS Local Coverage Determination
CONSHOHOCKEN, PA, November 6, 2025
Tiger BioSciences is pleased to announce that on November 1, 2025, it completed a submission of a comprehensive compendium of peer-reviewed clinical study results and scientific data to the Centers for Medicare & Medicaid Services (CMS) in aid of the new Local Coverage Determination (LCD) for Skin Substitutes.
…